RSS

Cell and Gene Therapy Catapult

Freeline, a biotechnology company focused on developing curative gene therapies for chronic systemic diseases, has secured a collaborative grant of £1.3 million from Innovate UK. Read more

News

Innovate UK has awarded £1.5 million to a contract development and manufacturing organisation (CDMO) focused on advanced therapy medicinal products (ATMPs). Read more

News

The CGT Catapult has signed a Memorandum of Understanding (MoU) with the FIRM in Japan, demonstrating a shared ambition to accelerate research and commercialisation of regenerative medicine. Read more

News

An award worth £12 million, from the government’s investment in healthcare and life sciences, will be used to expand the current size and capability of the Cell and Gene Therapy Catapult large-scale GMP Manufacturing Centre Read more

News

Gene and cell therapy group, Oxford BioMedica (OXB), has agreed to enter into a collaboration project as lead partner that will focus on gene and cell therapy manufacturing and will be co-funded by the UK’s innovation agency, Innovate UK. Read more

News